ArticleFuture oncology (London, England)2024

Transfusion-related cost offsets and time burden in patients with myelofibrosis on momelotinib vs. danazol from MOMENTUM.

Lucia Masarova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.